These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 9636186)

  • 1. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope.
    Vanderplasschen A; Mathew E; Hollinshead M; Sim RB; Smith GL
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7544-9. PubMed ID: 9636186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of incorporation of cellular antigens into vaccinia virus particles.
    Krauss O; Hollinshead R; Hollinshead M; Smith GL
    J Gen Virol; 2002 Oct; 83(Pt 10):2347-2359. PubMed ID: 12237415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody neutralization of the extracellular enveloped form of vaccinia virus.
    Law M; Smith GL
    Virology; 2001 Feb; 280(1):132-42. PubMed ID: 11162827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation.
    Vanderplasschen A; Hollinshead M; Smith GL
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():2041-8. PubMed ID: 9267005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular enveloped vaccinia virus escapes neutralization.
    Ichihashi Y
    Virology; 1996 Mar; 217(2):478-85. PubMed ID: 8610439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
    Parkinson JE; Smith GL
    Virology; 1994 Oct; 204(1):376-90. PubMed ID: 8091668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon.
    Lorenzo MM; Galindo I; Griffiths G; Blasco R
    J Virol; 2000 Nov; 74(22):10535-50. PubMed ID: 11044098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors.
    Vanderplasschen A; Smith GL
    J Virol; 1997 May; 71(5):4032-41. PubMed ID: 9094681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular and extracellular vaccinia virions enter cells by different mechanisms.
    Vanderplasschen A; Hollinshead M; Smith GL
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():877-87. PubMed ID: 9568984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular enveloped vaccinia virus. Entry, egress, and evasion.
    Smith GL; Vanderplasschen A
    Adv Exp Med Biol; 1998; 440():395-414. PubMed ID: 9782308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
    Bell E; Shamim M; Whitbeck JC; Sfyroera G; Lambris JD; Isaacs SN
    Virology; 2004 Aug; 325(2):425-31. PubMed ID: 15246280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).
    Spear GT; Lurain NS; Parker CJ; Ghassemi M; Payne GH; Saifuddin M
    J Immunol; 1995 Nov; 155(9):4376-81. PubMed ID: 7594597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.
    Aldaz-Carroll L; Whitbeck JC; Ponce de Leon M; Lou H; Hirao L; Isaacs SN; Moss B; Eisenberg RJ; Cohen GH
    J Virol; 2005 May; 79(10):6260-71. PubMed ID: 15858010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread.
    Law M; Hollinshead R; Smith GL
    J Gen Virol; 2002 Jan; 83(Pt 1):209-222. PubMed ID: 11752718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction.
    Saifuddin M; Hedayati T; Atkinson JP; Holguin MH; Parker CJ; Spear GT
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1907-11. PubMed ID: 9266986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain.
    Herrera E; Lorenzo MM; Blasco R; Isaacs SN
    J Virol; 1998 Jan; 72(1):294-302. PubMed ID: 9420227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yaba-like disease virus protein Y144R, a member of the complement control protein family, is present on enveloped virions that are associated with virus-induced actin tails.
    Law M; Hollinshead M; Lee HJ; Smith GL
    J Gen Virol; 2004 May; 85(Pt 5):1279-1290. PubMed ID: 15105545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutational analysis of the vaccinia virus B5R protein.
    Mathew EC; Sanderson CM; Hollinshead R; Smith GL
    J Gen Virol; 2001 May; 82(Pt 5):1199-1213. PubMed ID: 11297695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.